TERESA LOERA: Open Payments
NPI 1336614858 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,649 in 71 payments from 10 companies in 2025. Trend: 2023 $2,444 · 2024 $1,168 · 2025 $5,649
Consulting: $2,310Food & beverage: $1,899Travel & lodging: $1,441
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 36 | $4,639 |
| AstraZeneca Pharmaceuticals LP | 4 | $274 |
| ViiV Healthcare Company | 11 | $264 |
| Novo Nordisk Inc | 7 | $223 |
| Merck Sharp & Dohme LLC | 4 | $95 |
| Napo Pharmaceuticals Inc | 4 | $64 |
| Abbott Laboratories | 2 | $39 |
| Lilly USA, LLC | 1 | $22 |
| ABBVIE INC. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: Yeztugo, Ozempic, AIRSUPRA, DOVATO, BREZTRI, APRETUDE, PIFELTRO, Mytesi.
Industry payments across AZ — which companies pay providers there.
